{"@context": "https://schema.org", "@type": "BreadcrumbList", "itemListElement": [{"@type": "ListItem", "position": 1, "name": "Home", "item": "https://www.patentleaderboard.com/"}, {"@type": "ListItem", "position": 2, "name": "2021", "item": "https://www.patentleaderboard.com/2021/"}, {"@type": "ListItem", "position": 3, "name": "Bioatla", "item": "https://www.patentleaderboard.com/2021/company/bioatla"}, {"@type": "ListItem", "position": 4, "name": "Gerhard Frey", "item": "https://www.patentleaderboard.com/2021/inventor/fl:ge_ln:frey-2"}]}
Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
GF

Gerhard Frey — 3 Patents in 2021

BIBioatla: 3 patents #2 of 3Top 70%
San Diego, CA: #626 of 4,495 inventorsTop 15%
California: #8,414 of 66,859 inventorsTop 15%
Overall (2021): #82,889 of 548,734Top 20%
3 Patents 2021

Issued Patents 2021

Showing 1–3 of 3 patents

Patent #TitleCo-InventorsDateApprox Value ⓘ
11149088 Anti-Axl antibodies, antibody fragments and their immunoconjugates and uses thereof Jay M. Short, Hwai Wen Chang 2021-10-19 $15,274,000
11111288 Conditionally active chimeric antigen receptors for modified t-cells Jay M. Short, Hwai Wen Chang 2021-09-07 $20,126,000
10954288 Modified antibody regions and uses thereof Jay M. Short, Hwai Wen Chang 2021-03-23 $36,186,000